Active substance
Results for the substance gefitinib
9 results
About this active substance
Gefitinib is a medication used for the treatment of non-small cell lung cancer, particularly in patients with epidermal growth factor receptor (EGFR) mutations. It is a tyrosine kinase inhibitor.
This medication works by blocking signals that promote the growth and division of cancer cells. It is taken orally, usually once daily, as directed by a doctor.
Common side effects include diarrhea, skin rash, nausea, and fatigue. In rare cases, severe reactions such as interstitial lung disease may occur.
It is important to follow your doctor's instructions closely and report any side effects or unusual symptoms. Regular monitoring is necessary to assess treatment effectiveness.
This medication works by blocking signals that promote the growth and division of cancer cells. It is taken orally, usually once daily, as directed by a doctor.
Common side effects include diarrhea, skin rash, nausea, and fatigue. In rare cases, severe reactions such as interstitial lung disease may occur.
It is important to follow your doctor's instructions closely and report any side effects or unusual symptoms. Regular monitoring is necessary to assess treatment effectiveness.
-
-
GEFITINIB ACCORD 250mg film-coated tablets
-
GEFITINIB LABORMED 250mg film-coated tablets
-
PHROMPO 250mg film-coated tablets ALKALOID
-
GEFITINIB GLENMARK 250mg film-coated tablets
-
IRESSA 250mg film-coated tablets ASTRAZENECA ORIGINAL MEDICINE
-
GEFITINIB POLISANO 250mg film-coated tablets
-
GEFITINIB FLOMI 250mg film-coated tablets GENEPHARM
-
GEFITINIB SANDOZ 250mg film-coated tablets